The Swiss National Science Foundation and the Federal Council have approved the NCCR Children and Cancer, a nationwide research initiative dedicated to improving diagnostics and treatment for childhood cancers. The program connects leading hospitals and research institutions to accelerate progress in precision medicine and translational oncology.
At the Department of Quantitative Biomedicine at the University of Zurich, Bjoern Menze and Bernd Bodenmiller contribute expertise in biomedical data analysis and advanced AI methods for clinical decision support in pediatrics and pediatric oncology. Their work strengthens data driven approaches that aim to refine risk assessment, guide therapy selection, and improve outcomes for young patients through interdisciplinary collaboration.